much-hyped research compound targeting prolactin receptor in scalp
a potent but unapproved and potentially problematic topical anti-androgen
mitochondrial pyruvate carrier (MPC) inhibitor by Pelage in early trials
highly targeted anti-androgen that might have minimal systemic effects